SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse

Developmental Biology

Volumn 183, Issue 1, 1997, Pages 108-121

  Ng, Ling Jim ^a   Wheatley, Susan ^b   Muscat, George E O ^b   Conway Campbell, John ^b   Bowles, Jo ^b   Wright, Edwina ^b   Bell, Donald M ^a   Tam, Patrick P L ^c   Cheah, Kathryn S E ^a   Koopman, Peter ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHONDROGENESIS; DNA BINDING; EMBRYO; GENE DELETION; GENE EXPRESSION; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOX GENE; TRANSCRIPTION INITIATION;

ANIMALIA; MAMMALIA;

EID: 0031104994     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1006/dbio.1996.8487     Document Type: Article

References (55)

1. Carlson P., Waterman M., Jones K. The hLEF/TCF-1α HMG protein contains a context-dependent transcriptional activation domain that induces the TCRα enhancer in T cells. Genes Dev. 7:1993;2418-2430.
2. Cheah K. S. E., Lau E. T., Au P. K. C., Tam P. P. L. Expression of the mouse α1(II) collagen gene is not restricted to cartilage during development. Development. 111:1991;945-953.
3. Clerc R., Corcoran L., LeBowitz J., Baltimore D., Sharp D. The B-cell-specific Oct-2 protein contains POU-box and homeobox-type domains. Genes Dev. 2:1988;1570-1581.
4. Connor F., Wright E., Denny P., Koopman P., Ashworth A. TheSrySox6. Nucleic Acids Res. 23:1995;3365-3372.
5. Courey A., Tjian R. Analysis of Sp1in vivo. Cell. 55:1988;887-898.
6. Denny P., Swift S., Connor F., Ashworth A. AnSRY. EMBO J. 11:1992;3705-3712.
7. Dubin R. A., Ostrer H. Sry is a transcriptional activator. Mol. Endocrinol. 8:1994;1182-1192.
8. Dunn T. L., Mynett-Johnson L., Hosking B. M., Koopman P. A., Muscat G. E. O. Sequence and expression ofSox-18, Gene. 161:1995;223-225.
9. Erlebacher A., Filvaroff E. H., Gitelman S. E., Derynck R. Toward a molecular understanding of skeletal development. Cell. 80:1995;371-378.
10. Foster J. W., Dominguez-Steglich M. A., Guioli S., Kwok C., Weller P. A., Weissenbach J., Mansour S., Young I. D., Goodfellow P. N., Brook J. D., Schafer A. J. Campomelic dysplasia and autosomal sex reversal caused by mutations in anSRY. Nature. 372:1994;525-530.
11. Garofalo S., Vuorio E., Metsäranta M., Rosati R., Toman D., Vaughan J., Lozano G., Mayne R., Ellard J., Horton W. A., De Crombrugghe B. Reduced amounts of cartilage collagen fibrils and growth plate anomalies in transgenic mice harboring a glycine-to-cysteine mutation in the mouse type II procollagen α1-chain gene. Proc. Natl. Acad. Sci. USA. 88:1991;9648-9652.
12. Giese K., Grosschedl R. LEF-1 contains an activation domain that stimulates transcription only in a specific context of factor binding sites. EMBO J. 12:1993;4667-4676.
13. Gorman C. M., Moffat L. F., Howard B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell Biol. 2:1982;1044-1051.
14. Gubbay J., Collignon J., Koopman P., Capel B., Economou A., Münsterberg A., Vivian N., Goodfellow P., Lovell-Badge R. A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes. Nature. 346:1990;245-250.
15. Harley V. R., Lovell-Badge R., Goodfellow P. N. Definition of a concensus DNA binding site for SRY. Nucleic Acids Res. 22:1994;1500-1501.
16. Hosking B. M., Muscat G. E. O., Koopman P. A., Dowhan D. H., Dunn T. L. Trans. Nucleic Acids Res. 23:1995;2626-2628.
17. Houston C. S., Opitz J. M., Spranger J. W., Macpherson R. I., Reed M. H., Gilbert E. F., Herrmann J., Schinzel A. The campomelic syndrome: Review, report of 17 cases, and follow-up on the currently 17-year old boy first reported by Maroteaux et al. Am. J. Med. Genet. 15:1983;3-28.
18. Hovmoller M. L., Osuna A., Eklof O., Fredga K., Hjerpe A., Lindsten J., Ritzen M., Stanescu V., Svenningsen N. Camptomelic dwarfism. A genetically determined mesenchymal disorder combined with sex reversal. Hereditas. 86:1977;51-62.
19. Ito M., Ishikawa M., Suzuki S., Takamatsu N., Shiba T. A rainbow troutSRY. FEBS Lett. 377:1995;37-40.
20. Jay P., Gozé C., Marsollier C., Taviaux S., Hardelin J.-P., Koopman P., Berta P. The human SOX11 gene: Cloning, chromosomal assignment and tissue expression. Genomics. 29:1995;541-545.
21. Kamachi Y., Sockanathan S., Liu Q., Breitman M., Lovell-Badge R., Kondoh H. Involvement of SOX proteins in lens-specific activation of crystallin genes. EMBO J. 14:1995;3510-3519.
22. Kanai Y., Kanai-Azuma M., Noce T., Saido T. C., Shiroishi T., Hayashi Y., Yazaki K. Identification of two Sox17 messenger RNA isoforms, with and without the high mobility group box region, and their differential expression in mouse spermatogenesis. J. Cell Biol. 133:1996;1-15.
23. Kato G. J., Barrett J., Villa-Garcia M., Dang C. V. An amino-terminal c-myc domain required for neoplastic transformation activates transcription. Mol. Cell. Biol. 10:1990;5914-5920.
24. Kent J., Wheatley S. C., Andrews J. E., Sinclair A. H., Koopman P. A male-specific role forSOX9. Development. 122:1996;2813-2822.
25. Koopman P., Münsterberg A., Capel B., Vivian N., Lovell-Badge R. Expression of a candidate sex-determining gene during mouse testis differentiation. Nature. 348:1990;450-452.
26. Kosher R. A., Kulyk W. M., Gay S. W. Collagen gene expression during limb bud differentiation. J. Cell Biol. 102:1986;1151-1156.
27. Kravis D., Upholt W. B. Quantitation of type II procollagen mRNA levels during chick limb cartilage differentiation. Dev. Biol. 108:1985;164-172.
28. Kwok C., Weller P., Guioli S., Foster J. W., Mansour S., Zuffardi O., Punnett H. H., Dominguez-Steglich M. A., Brook J. D., Young I. D., Goodfellow P. N., Schafer A. J. Mutations inSOX9, Am. J. Hum. Genet. 57:1995;1028-1036.
29. Lee F. A., Issacs H., Strauss J. The 'camptomelic' syndrome. Short life-span dwarfism with respiratory distress, hypotonia, peculiar facies, and multiple skeletal and cartilaginous deformities. Am. J. Dis. Child. 124:1972;485-496.
30. Li S-W., Prockop D. J., Helminen H., Fassler R., Lapvetelainen T., Kiraly K., Peltarri A., Arokoski J., Lui H., Arita M., Khillan J. S. Transgenic mice with a targeted inactivation of the Col2a1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone. Genes Dev. 9:1995;2821-2830.
31. Lillie J. W., Green M. R. Transcription activation by the adenovirus E1a protein. Nature. 338:1989;39-44.
32. Metsäranta M., Garofalo S., Decker G., Rintala M., De Crombrugghe B., Vuorio E. Chondrodysplasia in transgenic mice harboring a 15-amino acid deletion in the triple helical domain of proα1(II) collagen chain. J. Cell Biol. 118:1992;203-212.
33. Metsäranta M., Toman D., De Crombrugghe B., Vuorio E. Mouse type II collagen gene. Complete nucleotide sequence, exon structure, and alternative splicing. J. Biol. Chem. 266:1991;16862-16869.
34. Mitchell P., Tjian R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science. 245:1989;371-378.
35. Morais da Silva S., Hacker A., Harley V., Goodfellow P., Swain A., Lovell-Badge R. Sox9. Nature Genet. 14:1996;62-68.
36. Ng L. J., Tam P. P. L., Cheah K. S. E. Preferential expression of alternatively spliced mRNAs encoding type II procollagen with a cysteine-rich amino-propeptide in differentiating cartilage and nonchondrogenic tissues during early mouse development. Dev. Biol. 159:1993;403-417.
37. Osborn L., Kunkel S., Nabel G. J. Tumour necrosis factor α and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear fcator κB. Proc. Natl. Acad. Sci. USA. 86:1989;2336-2340.
38. Ptashne M. How eukaryotic transcriptional activators work. Nature. 335:1988;683-689.
39. Ritvaniemi P., Korkko J., Bonaventure J., Vikkula M., Hyland J., Paasilta P., Kaitila I., Kaariainen H., Sokolov B. P., Hakala M., Mannismaki P., Meerson E. M., Klemola T., Williams C., Peltonen L., Kivirikko K. I., Prockop D. J., Ala-Kokko L. Analysis of the COL2A1 gene detects mutations in over 20 percent of patients with chondrodysplasias and up to 2 percent of patients with familial osteoarthritis. Arthritis Rheum. 38:1995;999-1004.
40. Rodriguez J. I. Vascular anomalies in campomelic syndrome. Am. J. Med. Genet. 46:1993;185-192.
41. Santoro C., Mermod N., Andrews P., Tjian R. A family of human CCAAT-box-binding proteins active in transcription and DNA replication: Cloning and expression of multiple cDNAs. Nature. 334:1988;218-224.
42. Schreiber E., Matthias P., Muller M. M., Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts,' prepared from a small number of cells. Nucleic Acids Res. 17:1989;6419.
43. Stevanovic M., Lovell-Badge R., Collignon J., Goodfellow P. N. SOX3SRY. Hum. Mol. Genet. 3:1993;2013-2018.
44. Südbeck P., Lienhard Schmitz M., Baeuerle P. A., Scherer G. Sex reversal by loss of the C-terminal transactivation domain of human SOX9. Nature Genet. 13:1996;230-232.
45. Swalla B. J., Upholt W. B., Solursh M. Analysis of type II collagen RNA localization in chick wing buds byin situ. Dev. Biol. 125:1988;51-58.
46. Tjian R., Maniatis T. Transcriptional activation: A complex puzzle with few easy pieces. Cell. 77:1994;5-8.
47. Tommerup N., Schempp W., Mienecke P., Pedersen S., Bolund L., Brandt C., Goodpasture C., Guldberg P., Held K. R., Reinwein H., Saaugstad O. D., Scherer G., Skjeldal O., Toder R., Westvik J., van der Hagen C. B., Wolf U. Assignment of an autosomal sex reversal locus (SRA1) and campomelic dysplasia (CMPD1) to 17q24.3-q25.1. Nature Genet. 4:1993;170-174.
48. Uwanogho D., Rex M., Cartwright E. J., Pearl G., Healy C., Scotting P., Sharpe P. T. Embryonic expression of the chicken Sox2, Sox3 and Sox11 genes suggests an interactive role in neural development. Mech. Dev. 49:1994;23-36.
49. Vandenberg P., Khillan J. S., Prockop D. J., Helminen H., Kontusaari S., Ala-Kokko L. Expression of a partially deleted gene of human type II procollagen (COL2A1. Proc. Natl. Acad. Sci. USA. 88:1991;7640-7644.
50. van de Wetering M., Oosterwegel M., van Norren K., Clevers H. Sox-4, an Sry-like HMG box protein, is a transcriptional activator in lymphocytes. EMBO J. 12:1993;3847-3854.
51. Vikkula M., Metsäranta M., Ala-Kokko L. Type II collagen mutations in rare and common cartilage diseases. Ann. Med. 26:1994;107-114.
52. Von der Mark K., Von der Mark H., Gay S. Immunological and biochemical studies of collagen type transition duringin vitro. J. Cell Biol. 73:1977;736-747.
53. Wagner T., Wirth J., Meyer J., Zabel B., Held M., Zimmer J., Pasantes J., Bricarelli F. D., Keutel J., Hustert E., Wolf U., Tommerup N., Schempp W., Scherer G. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around theSRYSOX9. Cell. 79:1994;1111-1120.
54. Wright E., Hargrave M. R., Christiansen J., Cooper L., Kun J., Evans T., Gangadharan U., Greenfield A., Koopman P. TheSrySox-9. Nature Genet. 9:1995;15-20.
55. Yuan H., Corbi N., Basilico C., Dailay L. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev. 9:1995;2635-3645.